Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress
- Brown University, United States
- University of Wyoming, United States
- University of Wyoming, School of Pharmacy, United States
Figures
Figure 1 with 1 supplement
norBNI rescues LTPGABA through activation of JNK.
(A) Summary data showing the blockade of LTPGABA after stress. (B) Comparison of the magnitude of LTPGABA10–15 min after SNAP application. (IPSC amplitudes, control: 140 ± 5% of baseline values, n = 13; stress: 94 ± 11% of baseline values, n = 6; unpaired t-test, *p=0.0005. (C) Schematic of norBNI’s competitive and non-competitive inhibition of κOR signaling. (D) Experimental design. (E) Representative single experiment showing that bath application of norBNI (100 nM) rescues LTPGABA in a slice prepared 24 hr after stress. (F) Representative single experiment from a slice prepared 24 hr after stress showing that norBNI does not rescue LTPGABA in the presence of the JNK inhibitor SP600125 (20 µM). (G) Summary data from both groups. (H) Comparison of the magnitude of LTPGABA10–15 min after SNAP application. (IPSC amplitudes, norBNI only: 139 ± 7% of baseline values, n = 6; norBNI+SP600125: 106 ± 9% of baseline values, n = 11; unpaired t-test, *p=0.029.) Insets for this and all figures: IPSCs before (black trace, control) and 15 min after drug application (red trace, SNAP, 400 µM). Scale bars: 20 ms, 100 pA. Insets are averages of 12 IPSCs.
Figure 1—figure supplement 1
Inhibition of JNK does not affect LTPGABA or its block by stress in the absence of norBNI.
(A) Summary data showing that LTPGABA is expressed in slices from naïve animals in the presence of the JNK inhibitor SP600125 (20 µM). Average magnitude of LTPGABA10–15 min after SNAP = 144 ± 13% of baseline values, n = 5; one-sample t-test, p=0.0257. (B) Summary data showing that LTPGABA remains blocked in slices from stressed animals in the presence of the JNK inhibitor SP600125 (20 µM). Average magnitude of LTPGABA10–15 min after SNAP = 111 ± 11% of baseline values, n = 6; one-sample t-test, p=0.38.
Figure 2 with 1 supplement
The neutral antagonist 6β-naltrexol fails to rescue LTPGABA in slices from stressed animals.
(A) Schematic of norBNI and 6β-naltrexol inhibition of κOR signaling. (B) Experimental design. (C) Representative experiment showing that bath application of norBNI (100 nM) rescues LTPGABA in a slice prepared 24 hr after stress. (D) Representative experiment from a cell 24 hr after stress showing that 6β-naltrexol (10 µM) fails to rescue LTPGABA. (E) Summary data from both groups. (F) Comparison of the magnitude of LTPGABA10–15 min after SNAP application. (IPSC amplitudes, norBNI: 141 ± 20% of baseline values, n = 10; 6β-naltrexol: 100 ± 8% of baseline values, n = 10; unpaired t-test, *p=0.048).
Figure 2—figure supplement 1
6β-naltrexol does not affect basal inhibitory synaptic transmission but does block κORs.
(A) Summary data showing that 6β-naltrexol (10 µM) does not affect basal inhibitory transmission in cells from control or stressed rats. Normalized IPSC amplitude 5–10 min after 6β-naltrexol: control = 97 ± 6% of baseline values, n = 6 (4 animals); stress = 92 ± 17% of baseline values, n = 4 (2 animals); unpaired t-test p=0.79. (B) Summary data showing that U50488 depresses EPSC amplitudes from VTA dopamine neurons and that 6β-naltrexol (10 µM) prevents this depression. Normalized EPSC amplitude 5–10 min after U50488: U50488 alone = 75 ± 2% of baseline values, n = 3; U50488 + 6β-naltrexol = 95 ± 1% of baseline values, n = 4; unpaired t-test *p=0.0003.
Figure 3
6β-naltrexol rescues LTPGABA when administered pre-stress, but not post-stress.
(A) Experimental design. (B) Representative experiment showing that a cell from a vehicle-treated stressed animal does not exhibit LTPGABA. (C) Representative experiment showing that a cell from an animal treated with 6β-naltrexol (10 mg/kg) 30 min pre-stress exhibits LTPGABA. (D) Representative experiment showing that a cell from an animal treated with 6β-naltrexol 24 hr post-stress does not exhibit LTPGABA. (E) Summary data showing compiled data from all groups. (F) Comparison of the magnitude of LTPGABA 10–15 min after SNAP application. (1-way ANOVA followed by Dunnett’s multiple comparison test. F2, 30=4.231,p=0.024. IPSC amplitudes, 6β-naltrexol pre-stress: 136 ± 12% of baseline values, n = 12, p<0.05 from vehicle; 6β-naltrexol post-stress: 100 ± 9% of baseline values, n = 11, n.s. from vehicle; vehicle+stress: 102 ± 8% of baseline values, n = 10).
Figure 4
Single treatment with a κOR agonist leads to prolonged blockade of LTPGABA.
(A) Experimental design. (B) Representative experiment showing that a cell from a saline-treated animal exhibits LTPGABA. (C) Representative single experiment showing a cell prepared 24 hr after a single treatment with U50488 (5 mg/kg) does not exhibit LTPGABA. (D) Representative experiment showing that a cell prepared five days after a single treatment with U50488 does not exhibit LTPGABA. (E) Summary data from all groups. (F) Comparison of the magnitude of LTPGABA10–15 min after SNAP application. (1-way ANOVA followed by Dunnett’s multiple comparison test. F2, 27=12.21, p=0.0002. IPSC amplitudes, Saline: 137 ± 6% of baseline values, n = 11; U50488 1 day: 108 ± 6% of baseline values, n = 9, p<0.05 vs. saline; U50488 5 days: 100 ± 5% of baseline values, n = 10, p<0.05 vs. saline).
Figure 5
κORs at VTA excitatory synapses are not constitutively activated by stress.
(A) Representative experiment showing that norBNI (100 nM) does not potentiate excitatory synapses on Ih+ VTA neurons in a slice prepared from a control animal. (B) Representative experiment showing that norBNI does not potentiate excitatory synapses on Ih+ VTA neurons in a slice prepared from a stressed animal. (C) Summary data from Ih+ neurons. No significant difference in IPSC amplitude 10–15 min after norBNI application (t-test p=0.81 IPSC amplitudes, control: 94 ± 2% of baseline values, n = 5; stressed: 92 ± 6% of baseline values, n = 6). (D) Representative experiment showing that norBNI does not potentiate excitatory synapses on Ih− VTA neurons in a slice prepared from a control animal. (E) Representative single experiment showing that norBNI does not potentiate excitatory synapses on Ih− VTA neurons in a slice prepared from a stressed animals. (F) Summary data from Ih− neurons. No significant difference in IPSC amplitude 10–15 min after norBNI application (t-test p=0.49 IPSC amplitudes, control: 112 ± 2% of baseline values, n = 5; stressed: 110 ± 4% of baseline values, n = 5).
Figure 6
Post-stress rescue of reinstatement by norBNI but not 6β-naltrexol.
(A) Experimental design. (B) Lever pressing during the final extinction session (white bar) and reinstatement session (colored bar). Saline (black): last extinction session: 6.4 ± 1.7 lever presses; reinstatement session: 13.8 ± 2.4 lever presses; n = 8, *p=0.011, paired t-test. norBNI (green): last extinction session: 4.8 ± 1.4 lever presses; reinstatement session: 5.2 ± 1.1 lever presses; n = 6, p=0.76, paired t-test. 6β-naltrexol (blue): last extinction session: 5.7 ± 1.8 lever presses; reinstatement session: 11.2 ± 3.4 lever presses; n = 11, *p=0.033, paired t-test.
Figure 7
Constitutive activation of κORs by stress.
(A) During stress, dynorphin binding to the κOR triggers a shift to a constitutively active state. By blocking dynorphin binding, both norBNI and 6β-naltrexol prevent the loss of LTPGABA during this time. (B) After stress, the block of LTPGABA is maintained by constitutive activity of κORs and is no longer dependent on dynorphin binding. (C) norBNI reverses the stress-induced block of LTPGABA by activating the JNK signaling pathway which non-competitively reduces κOR activity.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress
eLife 6:e23785.
https://doi.org/10.7554/eLife.23785
